Keyword: Eliquis


4. Eliquis

Pfizer and Bristol Myers Squibb’s Eliquis got a bit of a scare in January after the FDA approved the first generic version of their partnered blood thinner. But the companies’ aggressive patent litigation should stave off most copycats until 2026, leaving Eliquis with plenty of room to grow this year.

The top 10 drugs by sales increase in 2020

Some drugmakers work for years to take one of their meds from launch to blockbuster status—a journey defined by competition, market, branding and a dash of luck. But even for pharma's biggest whales, growth-minded executives have a question: What have you done for me lately? 
Advertising agency word cloud image

The top 10 ad spenders in Big Pharma for 2019

Direct-to-consumer drug ads tend to strike a dissonant chord. However, fan and foe can count on one thing: Prescription DTC advertising is here to stay. The evidence? Surviving more than 20 years of numerous legal, regulatory and perception challenges on its way to becoming a $6 billion-plus annual industry.